Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer

NCT02644863 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Esophageal Neoplasms
Neoplasms
Digestive System Neoplasms
Esophageal Cancer

Interventions

DRUG: Paclitaxel
BIOLOGICAL: DC-CIK
DRUG: Cisplatin

Sponsor

Shenzhen Hornetcorn Bio-technology Company, LTD

Collaborators

[object Object]